Author
Listed:
- Celso Eduardo Olivier
(Instituto Alergoimuno de Americana, Brasil)
- Daiana G. Pinto
(Instituto Alergoimuno de Americana, Brasil)
- Ana P. M. Teixeira
(Instituto Alergoimuno de Americana, Brasil)
- Jhéssica L. S. Santana
(Instituto Alergoimuno de Americana, Brasil)
- Raquel A. P. G. Santos
(Instituto Alergoimuno de Americana, Brasil)
- Regiane P. S. Lima
(Instituto Alergoimuno de Americana, Brasil)
Abstract
Background: Due to the lack of standardized laboratory procedures able to demonstrate specific non—IgE-mediated immune responses against latex allergens, these conditions are diagnosed mostly by clinical criteria based on empiric exclusion prescriptions monitored by in vivo challenge tests. Objective: To evaluate the opportunity of an ex vivo challenge immunoassay, the Leukocyte Adherence Inhibition (LAI) Test (LAIT), to discriminate non—IgE-mediated latex-specific immunoreactivity. Methods: Ex vivo challenge tests performed with Hevea Brasiliense’s latex extract, monitored by LAIT, were assayed in an asymptomatic control group and a group of patients with diverse respiratory and cutaneous non—IgE-mediated allergic conditions, clinically diagnosed by a certified allergologist. Results: The mean LAI of the control group was 8.3%. The mean LAI of the complete patients’ group was 41.1%. The non-parametric Wilcoxon-Mann-Whitney U (WMWU) test comparing the control group with the whole patient’s group showed significance with a p-value
Suggested Citation
Celso Eduardo Olivier & Daiana G. Pinto & Ana P. M. Teixeira & Jhéssica L. S. Santana & Raquel A. P. G. Santos & Regiane P. S. Lima, 2022.
"Contribution of the Leukocyte Adherence Inhibition Test to the Evaluation of Cellular Immunoreactivity against Latex Extracts for Non—IgE-Mediated Latex-Fruit-Pollen Syndrome in Allergic Candidates to Exclusion Diets and Allergic Desensitization,"
European Journal of Clinical Medicine, European Open Science, vol. 3(1), pages 11-17, January.
Handle:
RePEc:epw:clinic:v:3:y:2022:i:1:id:12160
DOI: 10.24018/clinicmed.2022.3.1.160
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:clinic:v:3:y:2022:i:1:id:12160. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/clinicmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.